The Canadian Clinical Trials Asset Map (CCTAM) – Signaling Canada’s clinical research...

15
CANADIAN CLINICAL TRIALS ASSET MAP (CCTAM) Elena Aminkova, CCTAM Project Manager CCTAM www.cctam.ca | [email protected]

Transcript of The Canadian Clinical Trials Asset Map (CCTAM) – Signaling Canada’s clinical research...

Page 1: The Canadian Clinical Trials Asset Map (CCTAM) – Signaling Canada’s clinical research strengths’ globally - Elena Aminkova

CANADIAN CLINICAL TRIALS ASSET MAP

(CCTAM)Elena Aminkova, CCTAM Project

Manager CCTAM

www.cctam.ca |[email protected]

Page 2: The Canadian Clinical Trials Asset Map (CCTAM) – Signaling Canada’s clinical research strengths’ globally - Elena Aminkova

WHAT IS CCTAM?• Part of the Action Plan to Help Attract More Clinical Trials to

Canada• Broad umbrella of stakeholders including Rx&D & member

companies, CIHR, DFATD, Health Canada, Industry Canada, HealthCareCAN, BCCRIN, CTO, N2 & independent research centers

• Web-based, “living”, easily searchable, interactive database of Canadian clinical research capabilities – researchers, clinical research sites, hospitals, institutions, research ethics boards, CROs, SMOs , etc. CCTAMwww.cctam.ca |

[email protected]

Page 3: The Canadian Clinical Trials Asset Map (CCTAM) – Signaling Canada’s clinical research strengths’ globally - Elena Aminkova

ABOUT CCTCC• Implementing recommendations emanating from

the Action Plan to Help Attract More Clinical Trials to Canada

• Funded by Rx&D, CIHR, HealthCareCAN. Housed at Health Charities Coalition of Canada

• Visit – www.cctcc.ca CCTCCwww.cctam.ca |[email protected]

Page 4: The Canadian Clinical Trials Asset Map (CCTAM) – Signaling Canada’s clinical research strengths’ globally - Elena Aminkova

CCTAM: OBJECTIVES• Showcase the tremendous assets we have in Canada to conduct clinical

trials• Better enable sponsors of clinical trials to identify clinical research sites

and investigators• Become a comprehensive database for all Canadian clinical research

assets; the essential tool for anyone planning on conducting clinical research in Canada

• Position Canada as an attractive destination for the conduct of clinical trials in the global marketplace  OBJECTIVESwww.cctam.ca |

[email protected]

Page 5: The Canadian Clinical Trials Asset Map (CCTAM) – Signaling Canada’s clinical research strengths’ globally - Elena Aminkova

CCTAM: DESIGN PRINCIPLES• Bilingual • Comprehensive data set• Regular updates• Easy to search • No cost to contributors to use

DESIGNwww.cctam.ca |[email protected]

Page 6: The Canadian Clinical Trials Asset Map (CCTAM) – Signaling Canada’s clinical research strengths’ globally - Elena Aminkova

WHO STANDS TO BENEFIT?• Research Sites and Investigators• Government, Federal & Provincial• Industry• Academia• Canadians

BENEFITwww.cctam.ca |[email protected]

Page 7: The Canadian Clinical Trials Asset Map (CCTAM) – Signaling Canada’s clinical research strengths’ globally - Elena Aminkova

CCTAM’S EXPERIENCE USING CASRAI• Overlap, e.g.:

o E.g. Health Sciences - Medical Sciences – Cardiology (Disciplines) o E.g. Health Sciences - Circulatory & Respiratory Health – Cardiovascular

Diseases (Subjects of Research) Challenge: Unable to put all research in a specific area under the same general heading

CLASSIFICATION SYSTEMwww.cctam.ca |

[email protected]

Page 8: The Canadian Clinical Trials Asset Map (CCTAM) – Signaling Canada’s clinical research strengths’ globally - Elena Aminkova

CCTAM’S EXPERIENCE USING CASRAI• Granularity, e.g.:

o Cardiology (under Medical Sciences in Disciplines)o Circulatory and Respiratory Health (in Subjects of Research) includes

granularity such as Arrhythmia & Heart FailureChallenge: Inconsistent search results

CLASSIFICATION SYSTEMwww.cctam.ca |

[email protected]

Page 9: The Canadian Clinical Trials Asset Map (CCTAM) – Signaling Canada’s clinical research strengths’ globally - Elena Aminkova

CCTAM’S EXPERIENCE USING CASRAI• Missing, e.g.:

o Infectious Diseases as a separate/independent medical science category o Vascular Medicine as a separate/independent medical science category

Challenge: Some lack of unifying categories

CLASSIFICATION SYSTEMwww.cctam.ca |

[email protected]

Page 10: The Canadian Clinical Trials Asset Map (CCTAM) – Signaling Canada’s clinical research strengths’ globally - Elena Aminkova

CCTAM’S RECOMMENDATIONS TO CASRAIAdd:• Clinical research sub-types, e.g. under “cardiology” – such

as arrhythmia & heart failure• Overall unifying categories e.g. Infectious Diseases &

Vascular Medicine• Category for Natural Products

CLASSIFICATION SYSTEMwww.cctam.ca |

[email protected]

Page 11: The Canadian Clinical Trials Asset Map (CCTAM) – Signaling Canada’s clinical research strengths’ globally - Elena Aminkova

CCTAM’S QUESTION TO CASRAI

• How are other CASRAI members applying the classification for clinical research?

CLASSIFICATION SYSTEMwww.cctam.ca |

[email protected]

Page 12: The Canadian Clinical Trials Asset Map (CCTAM) – Signaling Canada’s clinical research strengths’ globally - Elena Aminkova

PROGRESS TO DATE• Initial data collection & database software development

completed• Stage I and II of testing completed• CCTAM was launched – June 4, 2015; currently over 1000 assets • Cross-Canada CCTAM presentations were delivered• CCTAM Provincial Partnerships underway - BC Showcase was

launched • Federal Electoral Riding Search function added• Comprehensive Communications & Outreach Plan underwayPROGRESSwww.cctam.ca |

[email protected]

Page 13: The Canadian Clinical Trials Asset Map (CCTAM) – Signaling Canada’s clinical research strengths’ globally - Elena Aminkova

NEXT STEPS • Continue with data collection – adding REBs & patient

registries; more CROs & institutional and institutional investigators data

• Continue with stakeholder engagement• Continue CCTAM’s growth & development • Bilingual CCTAM website

NEXTwww.cctam.ca |[email protected]

Page 14: The Canadian Clinical Trials Asset Map (CCTAM) – Signaling Canada’s clinical research strengths’ globally - Elena Aminkova
Page 15: The Canadian Clinical Trials Asset Map (CCTAM) – Signaling Canada’s clinical research strengths’ globally - Elena Aminkova

CONTACT US. WE ARE ACCESSIBLE WEB: www.cctam.caEMAIL: [email protected]: Elena Aminkova, CCTAM Project Manager at 1-844-452-5818Twitter: @CCTAMap

CONTACTwww.cctam.ca |[email protected]